Conversations
Solving Civilizational Challenges with New Founding’s Joshua Clemans
Joshua Clemans is a venture partner at New Founding, a venture capital fund building and backing companies solving core problems shaping the future.
Conversations
Joshua Clemans is a venture partner at New Founding, a venture capital fund building and backing companies solving core problems shaping the future.
Conversations
Rahul Meka is a venture investor at Playground Global, an early-stage deep tech venture capital firm investing in technical founders to transform ambitious ideas into high-impact businesses.
Newsletters
Plus: CRISPR pigs approved for food, thermal vision breakthrough, quantum chip race intensifies, automated food lab heads to orbit, French startup develops space weapon, and more.
Conversations
Alexandru Tiliță is the co-founder and CEO of MatterWave, a company enhancing metal additive manufacturing with ultrasonic vibrations.
Conversations
Andrew Rush is the co-founder and CEO of Star Catcher, a company building new ways to power satellites through energy grids in space.
Newsletters
Plus: Night vision nanomaterials, geothermal gains ground, robotic pollinating bugs, China’s squeeze on rare-earth minerals, quantum computer cracks randomness, and more.
Conversations
John Forbes is principal at Julian Capital and COO of Deep Checks, a platform for deep tech founders to connect with thesis fit investors.
The most widely read newsletter in deep tech. Get exclusive interviews, deals, and news from the frontier in your inbox. Every Friday.
Plus: Avalanche's desktop fusion reactor, NASA's X-59 goes supersonic, NY lawmakers pass first in US data center moratorium, China's big bet on big nuclear reactors, and more.
Viktor Shpakovsky is an investment partner at Beyond Earth Ventures, a $30 million venture capital fund investing in transformative deep tech across space tech, robotics, energy, and compute.
Plus: Agtech investment is booming, SpaceX outlines plans for Starfall re-entry vehicles, AI executives call for stricter regulations on synthetic biology, the people who want AI to replace humanity, and more.
Brian Wilcove is the managing director of America's Frontier Fund (AFF), a sovereign-aligned venture capital firm investing in frontier technologies to strengthen U.S. innovation and economic competitiveness.
Plus: Blue Origin's mega-rocket explodes, race to mine the deep sea, IBM's first pure-play quantum chip foundry, NASA selects companies for moon base awards, and more.
Plus: Biomanufacturing to reshape organ transplants, grid batteries are booming, quantum's make-or-break moment, growing chickens in 3D printed eggs, Japan sells out of robot wolves, in-space refueling demo, and more.
Plus: Helium-3 lunar gold rush, Virgin Galactic to begin commercial service, Cowboy files for 20k orbital data centers, non-viral gene therapy, real life gundams, and more.
Plus: China opens rocket launches to international satellites, the future of IVF, a geothermal IPO, big tech targets drug discovery, DARPA eyes commercial space boom, and more.
Plus: Pentagon's drone spending spree, air taxis come to NYC, Zuck's virtual biology initiative, DeepSeek's new model, FDA wants to accelerate clinical trails with AI, and more.
Plus: New Glenn suffers upper stage malfunction, China ramps up satellite capacity, cracks in fusion's funding boom, robot marathon, slime-like artificial muscles, cocaine-fueled salmon, and more.
Paul Veugen is co-founder and partner at NP-Hard Ventures, an Amsterdam-based early-stage venture capital firm investing in pre-seed and seed companies solving the hardest problems across robotics, defense tech, and foundational infrastructure.
Plus: nuclear reactors on the moon, implantable pharmacies, 3D printing batteries, first complete human genome loaded onto quantum computer, Science Corp gets ready for brain implant, ARPA-E doubles down on fusion, and more.